Respiratory depression

Respiratory depression is a common physical side effect of many central nervous system depressants such as opioids, GHB, benzodiazepines (in combination with other depressants) and alcohol. This effect is manifested as a reduced urge to breathe and can cause a "sighing" pattern of breathing which can be described as deep breaths separated by abnormally long pauses. Sedation increases along with drug-induced respiratory depression.

This effect can be potentially life-threatening when depressants are taken in large doses or when combined with one another. In an overdose situation, an individual may cease breathing entirely (go into respiratory arrest) which is rapidly fatal without treatment.

Substance induced respiratory depression can be broken down into 4 separate levels of intensity which progressively intensify proportional to dosage:

1. Minimal respiratory depression: Minimal respiratory depression occurs on low doses of depressants. This effect is unnoticeable and is accompanied by mild sedation.
2. Moderate respiratory depression: As the dose increases, feelings of sedation intensify from moderate to high levels. One becomes aware of the sensation that the breath is slowed down mildly to moderately or that one is taking less breaths per minute than usual. This level of respiratory depression is not uncomfortable and does not result in any shortness, struggling, or impairment of breath.
3. Severe respiratory depression: Severe respiratory depression is impairing and occurs at dangerously high doses of depressants. At this level, a person's breathing rate becomes noticeably slowed down significantly which results in the feeling that one is not adequately moving air in and out of the body. Severe respiratory depression induces a powerful and overwhelming focus point of attention on one's breathing rate. In terms of how this feels physically, it can be described as the feeling that you are breathing abnormally, are short of breath, cannot breathe in enough air, and/or are forced to breathe manually in a conscious effort to feel that you are taking in enough air. Extreme sedation is present and if sleep occurs one may potentially wake up struggling and gasping for air. In cases of GHB overdoses, many reportedly experience an abnormal pattern of breathing characterized by progressively deeper and sometimes faster breathing, followed by a gradual decrease that results in a temporary stop in breathing called an apnea. Confusion and anxiety often occur at this level of heightened awareness, increasing the strong sensation that one's breathing will stop completely due to sleep or a lack of attention.
4. Respiratory failure: At this point, a person's oxygen and carbon dioxide levels become dangerously impaired. The person goes into a semi-conscious state, loses consciousness completely, slips into a coma, and/or stops breathing completely (respiratory arrest). The skin, fingernails, or lips may have a blue-ish color to them. This level of respiratory failure can be fatal without immediate medical attention. Opioids, in overdose or combined with other depressants, are notorious for such fatalities.

Treatment

To prevent death, it is recommended to contact emergency medical services immediately in case of severe respiratory depression. If caused by an opioid overdose, an opioid antagonist, such as naloxone, should be administered. Many harm reduction organizations provide naloxone to users for free or it can be bought at pharmacies (including Walgreens and CVS in the U.S.). Naloxone will rapidly reverse the respiratory depression unless complicated by other depressants. For other drug-induced respiratory depression, hospitalization and the assistance of a mechanical breathing machine may be necessary.

Psychoactive substances

Compounds within our psychoactive substance index which may cause this effect include:

• 1,4-Butanediol
• 2M2B
• 3-Cl-PCP
• 3-HO-PCE
• 3-HO-PCP
• 3-MeO-PCE
• 3-MeO-PCP
• 5-MeO-DMT
• Acetylfentanyl
• Alcohol
• Alprazolam
• Baclofen
• Barbiturates
• Benzodiazepines
• Bromazepam
• Buprenorphine
• Carisoprodol
• Clonazepam
• Clonazolam
• Codeine
• Datura
• Deschloroetizolam
• Desomorphine
• Dextropropoxyphene
• Diazepam
• Diclazepam
• Dihydrocodeine
• Eszopiclone
• Ethylmorphine
• Etizolam
• F-Phenibut
• Fentanyl
• Flualprazolam
• Flubromazepam
• Flubromazolam
• Flunitrazepam
• Flunitrazolam
• GBL
• GHB
• Haloperidol
• Heroin
• Hydrocodone
• Hydromorphone
• Lorazepam
• Methadone
• Methaqualone
• Metizolam
• Morphine
• Nifoxipam
• O-Desmethyltramadol

... further results

See also

• Responsible use
• Subjective effects index
• Psychedelics - Subjective effects
• Dissociatives - Subjective effects
• Deliriants - Subjective effects
• Depressants

References

Responsible drug use index